iPro Continuous Glucose Monitor Approved

Medtronic just received FDA clearance for its new physician-use continuous glucose monitoring (CGM) system dubbed iPro. Its smaller and lighter than other models of its type.

Patients wear the CGMS iPro Recorder for three days, after which physicians can review the data and use the results to uncover glucose patterns and optimize patient therapy. Based on the detailed glycemic profiles collected from the CGMS iPro Recorder, physicians can better tailor diabetes treatment programs for each patient. This may be particularly helpful for patients who experience inconsistent high and low glucose levels, who experience hypoglycemia unawareness and who generally desire better control, as well as for women with gestational diabetes and pregnant women with diabetes…
The CGMS iPro Recorder is attached to a tiny glucose sensor inserted just under the skin. During the course of three days, the recorder automatically measures and stores glucose values during daily activities like work, sleep, eating, and exercise. After the recording period is completed, the patient returns to the physician’s office where the device is removed and downloaded. The physician can then generate and interpret detailed glucose reports to determine changes to the patient’s therapy…
The CGMS iPro Recorder is attached to a tiny glucose sensor inserted just under the skin. During the course of three days, the recorder automatically measures and stores glucose values during daily activities like work, sleep, eating, and exercise. After the recording period is completed, the patient returns to the physician’s office where the device is removed and downloaded. The physician can then generate and interpret detailed glucose reports to determine changes to the patient’s therapy.

Press release: Simplified Evaluation Tool for Physicians to Personalize Diabetes Treatment Programs
Thoughts from Amy Tenderich at Diabetes Mine…